vs
BridgeBio Pharma, Inc.（BBIO）与GIBRALTAR INDUSTRIES, INC.（ROCK）财务数据对比。点击上方公司名可切换其他公司
GIBRALTAR INDUSTRIES, INC.的季度营收约是BridgeBio Pharma, Inc.的1.5倍（$225.0M vs $154.2M），BridgeBio Pharma, Inc.同比增速更快（2521.2% vs 24.9%），GIBRALTAR INDUSTRIES, INC.自由现金流更多（$26.2M vs $-56.5M）
本文提供的介绍实际对应 Brent Saunders 的个人履历，而非BridgeBio Pharma, Inc. 的企业信息。Brent Saunders是美国生物制药行业高管与企业家，目前担任博士伦公司董事长兼首席执行官，曾主导参与多起大型医药并购交易，同时涉足特殊目的收购公司领域，在医疗板块拥有丰富行业经验。
直布罗陀工业公司是专业建筑、基础设施及可再生能源产品制造商与分销商，主营通风系统、屋面配件、太阳能安装支架、园林景观产品等，主要服务北美地区住宅、商业建筑及清洁能源市场，专注提供创新可持续的客户解决方案。
BBIO vs ROCK — 直观对比
营收规模更大
ROCK
是对方的1.5倍
$154.2M
营收增速更快
BBIO
高出2496.2%
24.9%
自由现金流更多
ROCK
多$82.7M
$-56.5M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $154.2M | $225.0M |
| 净利润 | $-194.6M | — |
| 毛利率 | 94.7% | 25.3% |
| 营业利润率 | -90.5% | 7.9% |
| 净利率 | -126.2% | — |
| 营收同比 | 2521.2% | 24.9% |
| 净利润同比 | 27.2% | — |
| 每股收益（稀释后） | $-1.00 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BBIOROCK
| Q4 25 | $154.2M | $225.0M | ||
| Q3 25 | $120.7M | $310.9M | ||
| Q2 25 | $110.6M | $309.5M | ||
| Q1 25 | $116.6M | $290.0M | ||
| Q4 24 | — | $180.1M | ||
| Q3 24 | — | $277.1M | ||
| Q2 24 | — | $273.6M | ||
| Q1 24 | $211.1M | $292.5M |
净利润BBIOROCK
| Q4 25 | $-194.6M | — | ||
| Q3 25 | $-184.9M | $-89.1M | ||
| Q2 25 | $-183.8M | $26.0M | ||
| Q1 25 | $-169.6M | $21.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $34.0M | ||
| Q2 24 | — | $32.2M | ||
| Q1 24 | $-36.2M | $24.9M |
毛利率BBIOROCK
| Q4 25 | 94.7% | 25.3% | ||
| Q3 25 | 94.6% | 26.6% | ||
| Q2 25 | 96.7% | 28.4% | ||
| Q1 25 | 97.7% | 26.8% | ||
| Q4 24 | — | 29.0% | ||
| Q3 24 | — | 29.4% | ||
| Q2 24 | — | 30.5% | ||
| Q1 24 | 99.7% | 28.9% |
营业利润率BBIOROCK
| Q4 25 | -90.5% | 7.9% | ||
| Q3 25 | -120.3% | 12.8% | ||
| Q2 25 | -121.4% | 12.8% | ||
| Q1 25 | -89.5% | 8.8% | ||
| Q4 24 | — | 13.3% | ||
| Q3 24 | — | 15.6% | ||
| Q2 24 | — | 14.9% | ||
| Q1 24 | 0.2% | 10.8% |
净利率BBIOROCK
| Q4 25 | -126.2% | — | ||
| Q3 25 | -153.2% | -28.6% | ||
| Q2 25 | -166.2% | 8.4% | ||
| Q1 25 | -145.4% | 7.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 12.3% | ||
| Q2 24 | — | 11.8% | ||
| Q1 24 | -17.1% | 8.5% |
每股收益（稀释后）BBIOROCK
| Q4 25 | $-1.00 | — | ||
| Q3 25 | $-0.95 | $-2.98 | ||
| Q2 25 | $-0.95 | $0.87 | ||
| Q1 25 | $-0.88 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $1.11 | ||
| Q2 24 | — | $1.05 | ||
| Q1 24 | $-0.20 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $570.1M | $115.7M |
| 总债务越低越好 | $2.0B | $0 |
| 股东权益账面价值 | $-2.1B | $950.4M |
| 总资产 | $936.0M | $1.4B |
| 负债/权益比越低杠杆越低 | — | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资BBIOROCK
| Q4 25 | $570.1M | $115.7M | ||
| Q3 25 | $643.0M | $89.4M | ||
| Q2 25 | $756.9M | $43.3M | ||
| Q1 25 | $540.6M | $25.1M | ||
| Q4 24 | — | $269.5M | ||
| Q3 24 | — | $228.9M | ||
| Q2 24 | — | $179.1M | ||
| Q1 24 | $519.7M | $146.7M |
总债务BBIOROCK
| Q4 25 | $2.0B | $0 | ||
| Q3 25 | $2.0B | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $0 | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | $0 |
股东权益BBIOROCK
| Q4 25 | $-2.1B | $950.4M | ||
| Q3 25 | $-1.9B | $951.8M | ||
| Q2 25 | $-1.8B | $1.0B | ||
| Q1 25 | $-1.6B | $1.0B | ||
| Q4 24 | — | $1.0B | ||
| Q3 24 | — | $1.0B | ||
| Q2 24 | — | $975.7M | ||
| Q1 24 | $-1.0B | $940.2M |
总资产BBIOROCK
| Q4 25 | $936.0M | $1.4B | ||
| Q3 25 | $998.3M | $1.4B | ||
| Q2 25 | $1.1B | $1.5B | ||
| Q1 25 | $881.6M | $1.4B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | — | $1.4B | ||
| Q1 24 | $849.3M | $1.3B |
负债/权益比BBIOROCK
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-56.4M | $35.5M |
| 自由现金流经营现金流 - 资本支出 | $-56.5M | $26.2M |
| 自由现金流率自由现金流/营收 | -36.6% | 11.7% |
| 资本支出强度资本支出/营收 | 0.0% | 4.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $120.6M |
8季度趋势，按日历期对齐
经营现金流BBIOROCK
| Q4 25 | $-56.4M | $35.5M | ||
| Q3 25 | $-109.6M | $73.0M | ||
| Q2 25 | $-80.7M | $44.9M | ||
| Q1 25 | $-199.2M | $13.7M | ||
| Q4 24 | — | $19.9M | ||
| Q3 24 | — | $64.7M | ||
| Q2 24 | — | $36.5M | ||
| Q1 24 | $-219.5M | $53.2M |
自由现金流BBIOROCK
| Q4 25 | $-56.5M | $26.2M | ||
| Q3 25 | $-110.0M | $64.8M | ||
| Q2 25 | $-81.3M | $27.3M | ||
| Q1 25 | — | $2.3M | ||
| Q4 24 | — | $14.1M | ||
| Q3 24 | — | $60.5M | ||
| Q2 24 | — | $33.5M | ||
| Q1 24 | $-220.2M | $48.8M |
自由现金流率BBIOROCK
| Q4 25 | -36.6% | 11.7% | ||
| Q3 25 | -91.2% | 20.8% | ||
| Q2 25 | -73.5% | 8.8% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | — | 7.8% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | 12.2% | ||
| Q1 24 | -104.3% | 16.7% |
资本支出强度BBIOROCK
| Q4 25 | 0.0% | 4.1% | ||
| Q3 25 | 0.4% | 2.6% | ||
| Q2 25 | 0.5% | 5.7% | ||
| Q1 25 | 0.0% | 3.9% | ||
| Q4 24 | — | 3.3% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | 0.3% | 1.5% |
现金转化率BBIOROCK
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.73× | ||
| Q1 25 | — | 0.65× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | — | 1.13× | ||
| Q1 24 | — | 2.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BBIO
暂无分部数据
ROCK
| Transferred At Point In Time | $183.5M | 82% |
| Infrastructure | $22.5M | 10% |
| Other | $18.9M | 8% |
